Organisation paid for research Program year 2025 Source: CMS Open Payments

Activian Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$432,999

15 payments

Through program year 2025, Activian Clinical Research is reported as receiving $432,999 in research payments, across 15 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$64,524	7
2024	Research	$173,275	4
2023	Research	$195,200	4

Breakdown

Who paid Research payments · program years 2023–2025

Gen-Probe, Inc. $253,625 6 payments
Sekisui Diagnostics LLC $163,050 3 payments
Moderna TX, Inc. $11,300 1 payment
Roche Molecular Systems, Inc. $5,024 5 payments

Studies the money was for Research payments · program years 2023–2025

A10940-SC2/FluP-CSP-02 $195,200 4 payments
Human Factors and Clinical Validation of the SEKISUI OSOM Flu SARS-CoV-2 Combo Home Test in Anterior Nares Nasal Samples For Over-the-Counter (OTC) Use $104,550 2 payments
Clinical Validation of the SEKISUI OSOM Flu A&B Test in Anterior Nares Nasal Samples For Over-the Counter (OTC) Use $58,500 1 payment
655-A10960-001 $58,425 2 payments
A Phase 3, randomized, observerblind, activecontrol study to evaluate the safety, reactogenicity, and immunogenicity of mRNA1083 (SARSCoV2 and influenza) vaccine in healthy adult participants, 50 years of age. $11,300 1 payment
Rd007372 $5,024 5 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.